Protein misfolding specifies recruitment to cytoplasmic inclusion bodies

Journal of Cell Biology

Volumn 213, Issue 2, 2016, Pages 229-241

  Bersuker, Kirill ^a   Brandeis, Michael ^b   Kopito, Ron R ^a  

^a STANFORD UNIVERSITY   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN; UBIQUITIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL INCLUSION; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN METABOLISM; PROTEIN MISFOLDING; PROTEIN STRUCTURE; PROTEIN TARGETING; UBIQUITINATION; AUTOPHAGY; CELL LINE; CYTOPLASM; METABOLISM; PROTEIN TRANSPORT; TIME LAPSE IMAGING; ULTRASTRUCTURE;

AUTOPHAGY; CELL LINE; CYTOPLASM; HUMANS; INCLUSION BODIES; PROTEIN FOLDING; PROTEIN TRANSPORT; TIME-LAPSE IMAGING; UBIQUITINATION;

EID: 84969135605     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201511024     Document Type: Article

References (70)

1. Arrasate, M., S. Mitra, E.S. Schweitzer, M.R. Segal, and S. Finkbeiner. 2004. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 431:805-810. http://dx.doi.org/10.1038/nature02998
2. Atkin, G., and H. Paulson. 2014. Ubiquitin pathways in neurodegenerative disease. Front. Mol. Neurosci. 7:63. http://dx.doi.org/10.3389/fnmol.2014.00063
3. Banaszynski, L.A., L.C. Chen, L.A. Maynard-Smith, A.G. Ooi, and T.J. Wandless. 2006. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell. 126:995-1004. http://dx.doi.org/10.1016/j.cell.2006.07.025
4. Bence, N.F., R.M. Sampat, and R.R. Kopito. 2001. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 292:1552-1555. http://dx.doi.org/10.1126/science.292.5521.1552
5. Bennett, E.J., N.F. Bence, R. Jayakumar, and R.R. Kopito. 2005. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol. Cell. 17:351-365. http://dx.doi.org/10.1016/j.molcel.2004.12.021
6. Bennett, E.J., T.A. Shaler, B. Woodman, K.-Y. Ryu, T.S. Zaitseva, C.H. Becker, G.P. Bates, H. Schulman, and R.R. Kopito. 2007. Global changes to the ubiquitin system in Huntington's disease. Nature. 448:704-708. http://dx.doi.org/10.1038/nature06022
7. Bersuker, K., M.S. Hipp, B. Calamini, R.I. Morimoto, and R.R. Kopito. 2013. Heat shock response activation exacerbates inclusion body formation in a cellular model of Huntington disease. J. Biol. Chem. 288:23633-23638. http://dx.doi.org/10.1074/jbc.C113.481945
8. Bett, J.S., C. Cook, L. Petrucelli, and G.P. Bates. 2009. The ubiquitin-proteasome reporter GFPu does not accumulate in neurons of the R6/2 transgenic mouse model of Huntington's disease. PLoS One. 4:e5128. http://dx.doi.org/10.1371/journal.pone.0005128
9. Bhat, K.P., S. Yan, C.-E. Wang, S. Li, and X.-J. Li. 2014. Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A. Proc. Natl. Acad. Sci. USA. 111:5706-5711. http://dx.doi.org/10.1073/pnas.1402215111
10. Bové, J., M. Martínez-Vicente, and M. Vila. 2011. Fighting neurodegeneration with rapamycin: mechanistic insights. Nat. Rev. Neurosci. 12:437-452. http://dx.doi.org/10.1038/nrn3068
11. Chen, J.J., C.A. Tsu, J.M. Gavin, M.A. Milhollen, F.J. Bruzzese, W.D. Mallender, M.D. Sintchak, N.J. Bump, X. Yang, J. Ma, et al. 2011. Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analogues. J. Biol. Chem. 286:40867-40877. http://dx.doi.org/10.1074/jbc.M111.279984
12. Dantuma, N.P., and L.C. Bott. 2014. The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution. Front. Mol. Neurosci. 7:70. http://dx.doi.org/10.3389/fnmol.2014.00070
13. Dantuma, N.P., K. Lindsten, R. Glas, M. Jellne, and M.G. Masucci. 2000. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat. Biotechnol. 18:538-543. http://dx.doi.org/10.1038/75406
14. Davies, S.W., M. Turmaine, B.A. Cozens, M. DiFiglia, A.H. Sharp, C.A. Ross, E. Scherzinger, E.E. Wanker, L. Mangiarini, and G.P. Bates. 1997. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 90:537-548. http://dx.doi.org/10.1016/S0092-8674(00)80513-9
15. DiFiglia, M., E. Sapp, K.O. Chase, S.W. Davies, G.P. Bates, J.P. Vonsattel, and N. Aronin. 1997. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 277:1990-1993. http://dx.doi.org/10.1126/science.277.5334.1990
16. Egeler, E.L., L.M. Urner, R. Rakhit, C.W. Liu, and T.J. Wandless. 2011. Ligand-switchable substrates for a ubiquitin-proteasome system. J. Biol. Chem. 286:31328-31336. http://dx.doi.org/10.1074/jbc.M111.264101
17. Eliezer, D., E. Kutluay, R. Bussell Jr., and G. Browne. 2001. Conformational properties of a-synuclein in its free and lipid-associated states. J. Mol. Biol. 307:1061-1073. http://dx.doi.org/10.1006/jmbi.2001.4538
18. Frydman, J., E. Nimmesgern, K. Ohtsuka, and F.U. Hartl. 1994. Folding of nascent polypeptide chains in a high molecular mass assembly with molecular chaperones. Nature. 370:111-117. http://dx.doi.org/10.1038/370111a0
19. Fuentealba, R.A., M. Udan, S. Bell, I. Wegorzewska, J. Shao, M.I. Diamond, C.C. Weihl, and R.H. Baloh. 2010. Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43. J. Biol. Chem. 285:26304-26314. http://dx.doi.org/10.1074/jbc.M110.125039
20. Furukawa, Y., K. Kaneko, G. Matsumoto, M. Kurosawa, and N. Nukina. 2009. Cross-seeding fibrillation of Q/N-rich proteins offers new pathomechanism of polyglutamine diseases. J. Neurosci. 29:5153-5162. http://dx.doi.org/10.1523/JNEUROSCI.0783-09.2009
21. García-Mata, R., Z. Bebök, E.J. Sorscher, and E.S. Sztul. 1999. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J. Cell Biol. 146:1239-1254. http://dx.doi.org/10.1083/jcb.146.6.1239
22. Gidalevitz, T., A. Ben-Zvi, K.H. Ho, H.R. Brignull, and R.I. Morimoto. 2006. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science. 311:1471-1474. http://dx.doi.org/10.1126/science.1124514
23. Gong, B., C. Kielar, and A.J. Morton. 2012. Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington's disease mutation. PLoS One. 7:e41450. http://dx.doi.org/10.1371/journal.pone.0041450
24. Gupta, R., P. Kasturi, A. Bracher, C. Loew, M. Zheng, A. Villella, D. Garza, F.U. Hartl, and S. Raychaudhuri. 2011. Firefly luciferase mutants as sensors of proteome stress. Nat. Methods. 8:879-884. http://dx.doi.org/10.1038/nmeth.1697
25. Hartl, F.U., A. Bracher, and M. Hayer-Hartl. 2011. Molecular chaperones in protein folding and proteostasis. Nature. 475:324-332. http://dx.doi.org/10.1038/nature10317
26. Hipp, M.S., C.N. Patel, K. Bersuker, B.E. Riley, S.E. Kaiser, T.A. Shaler, M. Brandeis, and R.R. Kopito. 2012. Indirect inhibition of 26S proteasome activity in a cellular model of Huntington's disease. J. Cell Biol. 196:573-587. http://dx.doi.org/10.1083/jcb.201110093
27. Hipp, M.S., S.-H. Park, and F.U. Hartl. 2014. Proteostasis impairment in proteinmisfolding and -aggregation diseases. Trends Cell Biol. 24:506-514. http://dx.doi.org/10.1016/j.tcb.2014.05.003
28. Ii, K., H. Ito, K. Tanaka, and A. Hirano. 1997. Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. J. Neuropathol. Exp. Neurol. 56:125-131. http://dx.doi.org/10.1097/00005072-199702000-00002
29. Iwamoto, M., T. Björklund, C. Lundberg, D. Kirik, and T.J. Wandless. 2010. A general chemical method to regulate protein stability in the mammalian central nervous system. Chem. Biol. 17:981-988. http://dx.doi.org/10.1016/j.chembiol.2010.07.009
30. Iwata, A., B.E. Riley, J.A. Johnston, and R.R. Kopito. 2005. HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J. Biol. Chem. 280:40282-40292. http://dx.doi.org/10.1074/jbc.M508786200
31. Johnson, E.S., B. Bartel, W. Seufert, and A. Varshavsky. 1992. Ubiquitin as a degradation signal. EMBO J. 11:497-505.
32. Johnston, J.A., C.L. Ward, and R.R. Kopito. 1998. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143:1883-1898. http://dx.doi.org/10.1083/jcb.143.7.1883
33. Kawaguchi, Y., J.J. Kovacs, A. McLaurin, J.M. Vance, A. Ito, and T.P. Yao. 2003. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell. 115:727-738. http://dx.doi.org/10.1016/S0092-8674(03)00939-5
34. Kayatekin, C., K.E.S. Matlack, W.R. Hesse, Y. Guan, S. Chakrabortee, J. Russ, E.E. Wanker, J.V. Shah, and S. Lindquist. 2014. Prion-like proteins sequester and suppress the toxicity of huntingtin exon 1. Proc. Natl. Acad. Sci. USA. 111:12085-12090. http://dx.doi.org/10.1073/pnas.1412504111
35. Koegl, M., T. Hoppe, S. Schlenker, H.D. Ulrich, T.U. Mayer, and S. Jentsch. 1999. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell. 96:635-644. http://dx.doi.org/10.1016/S0092-8674(00)80574-7
36. Lamark, T., and T. Johansen. 2012. Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int. J. Cell Biol. 2012. http://dx.doi.org/10.1155/2012/736905
37. Lee, H.-J., and S.-J. Lee. 2002. Characterization of cytoplasmic a-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. J. Biol. Chem. 277:48976-48983. http://dx.doi.org/10.1074/jbc.M208192200
38. Lowe, J., A. Blanchard, K. Morrell, G. Lennox, L. Reynolds, M. Billett, M. Landon, and R.J. Mayer. 1988. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J. Pathol. 155:9-15. http://dx.doi.org/10.1002/path.1711550105
39. MacDonald, M.E., C.M. Ambrose, M.P. Duyao, R.H. Myers, C. Lin, L. Srinidhi, G. Barnes, S.A. Taylor, M. James, N. Groot, et al. The Huntington's Disease Collaborative Research Group. 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:971-983. http://dx.doi.org/10.1016/0092-8674(93)90585-E
40. Mangiarini, L., K. Sathasivam, M. Seller, B. Cozens, A. Harper, C. Hetherington, M. Lawton, Y. Trottier, H. Lehrach, S.W. Davies, and G.P. Bates. 1996. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87:493-506. http://dx.doi.org/10.1016/S0092-8674(00)81369-0
41. Margulis, J., and S. Finkbeiner. 2014. Proteostasis in striatal cells and selective neurodegeneration in Huntington's disease. Front. Cell. Neurosci. 8:218. http://dx.doi.org/10.3389/fncel.2014.00218
42. Maynard, C.J., C. Böttcher, Z. Ortega, R. Smith, B.I. Florea, M. Díaz-Hernández, P. Brundin, H.S. Overkleeft, J.-Y. Li, J.J. Lucas, and N.P. Dantuma. 2009. Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment. Proc. Natl. Acad. Sci. USA. 106:13986-13991. http://dx.doi.org/10.1073/pnas.0906463106
43. Menalled, L.B. 2005. Knock-in mouse models of Huntington's disease. NeuroRx. 2:465-470. http://dx.doi.org/10.1602/neurorx.2.3.465
44. Miller, S.B., C.-T. Ho, J. Winkler, M. Khokhrina, A. Neuner, M.Y. Mohamed, D.L. Guilbride, K. Richter, M. Lisby, E. Schiebel, et al. 2015. Compartment-specific aggregases direct distinct nuclear and cytoplasmic aggregate deposition. EMBO J. 34:778-797. http://dx.doi.org/10.15252/embj.201489524
45. Morales, R., I. Moreno-Gonzalez, and C. Soto. 2013. Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases. PLoS Pathog. 9:e1003537. http://dx.doi.org/10.1371/journal.ppat.1003537
46. Nagaoka, U., K. Kim, N.R. Jana, H. Doi, M. Maruyama, K. Mitsui, F. Oyama, and N. Nukina. 2004. Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions. J. Neurochem. 91:57-68. http://dx.doi.org/10.1111/j.1471-4159.2004.02692.x
47. Olzmann, J.A., L. Li, M.V. Chudaev, J. Chen, F.A. Perez, R.D. Palmiter, and L.-S. Chin. 2007. Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J. Cell Biol. 178:1025-1038. http://dx.doi.org/10.1083/jcb.200611128
48. Ormsby, A.R., Y.M. Ramdzan, Y.-F. Mok, K.D. Jovanoski, and D.M. Hatters. 2013. A platform to view huntingtin exon 1 aggregation flux in the cell reveals divergent influences from chaperones hsp40 and hsp70. J. Biol. Chem. 288:37192-37203. http://dx.doi.org/10.1074/jbc.M113.486944
49. Ortega, Z., M. Díaz-Hernández, C.J. Maynard, F. Hernández, N.P. Dantuma, and J.J. Lucas. 2010. Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation. J. Neurosci. 30:3675-3688. http://dx.doi.org/10.1523/JNEUROSCI.5673-09.2010
50. Park, S.-H., Y. Kukushkin, R. Gupta, T. Chen, A. Konagai, M.S. Hipp, M. Hayer-Hartl, and F.U. Hartl. 2013. PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone. Cell. 154:134-145. http://dx.doi.org/10.1016/j.cell.2013.06.003
51. Qian, S.-B., D.E. Ott, U. Schubert, J.R. Bennink, and J.W. Yewdell. 2002. Fusion proteins with COOH-terminal ubiquitin are stable and maintain dual functionality in vivo. J. Biol. Chem. 277:38818-38826. http://dx.doi.org/10.1074/jbc.M205547200
52. Raasi, S., R. Varadan, D. Fushman, and C.M. Pickart. 2005. Diverse polyubiquitin interaction properties of ubiquitin-associated domains. Nat. Struct. Mol. Biol. 12:708-714. http://dx.doi.org/10.1038/nsmb962
53. Ramdzan, Y.M., S. Polling, C.P.Z. Chia, I.H.W. Ng, A.R. Ormsby, N.P. Croft, A.W. Purcell, M.A. Bogoyevitch, D.C.H. Ng, P.A. Gleeson, and D.M. Hatters. 2012. Tracking protein aggregation and mislocalization in cells with flow cytometry. Nat. Methods. 9:467-470. http://dx.doi.org/10.1038/nmeth.1930
54. Riley, B.E., S.E. Kaiser, T.A. Shaler, A.C.Y. Ng, T. Hara, M.S. Hipp, K. Lage, R.J. Xavier, K.-Y. Ryu, K. Taguchi, et al. 2010. Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection. J. Cell Biol. 191:537-552. http://dx.doi.org/10.1083/jcb.201005012
55. Ross, C.A., and M.A. Poirier. 2004. Protein aggregation and neurodegenerative disease. Nat. Med. 10(7, Suppl):S10-S17. http://dx.doi.org/10.1038/nm1066
56. Ross, C.A., and M.A. Poirier. 2005. Opinion: What is the role of protein aggregation in neurodegeneration? Nat. Rev. Mol. Cell Biol. 6:891-898. http://dx.doi.org/10.1038/nrm1742
57. Sampathu, D.M., B.I. Giasson, A.C. Pawlyk, J.Q. Trojanowski, and V.M.-Y. Lee. 2003. Ubiquitination of a-synuclein is not required for formation of pathological inclusions in a-synucleinopathies. Am. J. Pathol. 163:91-100. http://dx.doi.org/10.1016/S0002-9440(10)63633-4
58. Scherzinger, E., R. Lurz, M. Turmaine, L. Mangiarini, B. Hollenbach, R. Hasenbank, G.P. Bates, S.W. Davies, H. Lehrach, and E.E. Wanker. 1997. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell. 90:549-558. http://dx.doi.org/10.1016/S0092-8674(00)80514-0
59. Scherzinger, E., A. Sittler, K. Schweiger, V. Heiser, R. Lurz, R. Hasenbank, G.P. Bates, H. Lehrach, and E.E. Wanker. 1999. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl. Acad. Sci. USA. 96:4604-4609. http://dx.doi.org/10.1073/pnas.96.8.4604
60. Schipper-Krom, S., K. Juenemann, A.H. Jansen, A. Wiemhoefer, R. van den Nieuwendijk, D.L. Smith, M.A. Hink, G.P. Bates, H. Overkleeft, H. Ovaa, and E. Reits. 2014. Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies. FEBS Lett. 588:151-159. http://dx.doi.org/10.1016/j.febslet.2013.11.023
61. Steffan, J.S., N. Agrawal, J. Pallos, E. Rockabrand, L.C. Trotman, N. Slepko, K. Illes, T. Lukacsovich, Y.-Z. Zhu, E. Cattaneo, et al. 2004. SUMO modification of Huntingtin and Huntington's disease pathology. Science. 304:100-104. http://dx.doi.org/10.1126/science.1092194
62. Tan, J.M.M., E.S.P. Wong, D.S. Kirkpatrick, O. Pletnikova, H.S. Ko, S.-P. Tay, M.W.L. Ho, J. Troncoso, S.P. Gygi, M.K. Lee, et al. 2008. Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum. Mol. Genet. 17:431-439. http://dx.doi.org/10.1093/hmg/ddm320
63. Tofaris, G.K., A. Razzaq, B. Ghetti, K.S. Lilley, and M.G. Spillantini. 2003. Ubiquitination of a-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J. Biol. Chem. 278:44405-44411. http://dx.doi.org/10.1074/jbc.M308041200
64. Tsvetkov, A.S., M. Arrasate, S. Barmada, D.M. Ando, P. Sharma, B.A. Shaby, and S. Finkbeiner. 2013. Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration. Nat. Chem. Biol. 9:586-592. http://dx.doi.org/10.1038/nchembio.1308
65. Verhoef, L.G.G.C., K. Lindsten, M.G. Masucci, and N.P. Dantuma. 2002. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins. Hum. Mol. Genet. 11:2689-2700. http://dx.doi.org/10.1093/hmg/11.22.2689
66. Waelter, S., A. Boeddrich, R. Lurz, E. Scherzinger, G. Lueder, H. Lehrach, and E.E. Wanker. 2001. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol. Biol. Cell. 12:1393-1407. http://dx.doi.org/10.1091/mbc.12.5.1393
67. Wetzel, R. 2012. Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence. J. Mol. Biol. 421:466-490. http://dx.doi.org/10.1016/j.jmb.2012.01.030
68. Wigley, W.C., R.P. Fabunmi, M.G. Lee, C.R. Marino, S. Muallem, G.N. DeMartino, and P.J. Thomas. 1999. Dynamic association of proteasomal machinery with the centrosome. J. Cell Biol. 145:481-490. http://dx.doi.org/10.1083/jcb.145.3.481
69. Yao, T.-P. 2010. The role of ubiquitin in autophagy-dependent protein aggregate processing. Genes Cancer. 1:779-786. http://dx.doi.org/10.1177/1947601910383277
70. Yu, A., Y. Shibata, B. Shah, B. Calamini, D.C. Lo, and R.I. Morimoto. 2014. Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition. Proc. Natl. Acad. Sci. USA. 111:E1481-E1490. http://dx.doi.org/10.1073/pnas.1321811111